Feasibility and cost analysis of day 4 granulocyte colony-stimulating factor mobilized peripheral blood progenitor cell collection from HLA-matched sibling donors-Reference-Cited by-同舟云学术

Feasibility and cost analysis of day 4 granulocyte colony-stimulating factor mobilized peripheral blood progenitor cell collection from HLA-matched sibling donors

Published:2019-07 Issue:7 Volume:21 Page:725-737
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Newell Laura F.,Shoop Kelsea M.,Knight Rebekah J.,Murray Sara N.,Kwock Rogelyn P.,Jacoby Carol E.,Slater Susan,Allen Bryon E.,Ottowa Casondra,Cota Brad,Appel Peggy L.,Cook Rachel J.,Maziarz Richard T.,Meyers Gabrielle

Funder

National Institute of Child Health and Human Development

Novartis

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics(clinical),Oncology,Immunology,Immunology and Allergy

Reference43 articles.

1. D'Souza A, Zhu, X. Current Uses and Outcomes of Hematopoietic Cell Transplantation (HCT): CIBMTR Summary Slides, 2016.

2. Peripheral blood progenitor cell mobilization for autologous and allogeneic hematopoietic cell transplantation: guidelines from the American Society for Blood and Marrow Transplantation;Duong;Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation,2014

3. Efficacy and toxicity of a high-dose G-CSF schedule for peripheral blood progenitor cell mobilization in healthy donors;Martinez;Bone Marrow Transplant,1999

4. High-versus standard-dose filgrastim (rhG-CSF) for mobilization of peripheral-blood progenitor cells from allogeneic donors and CD34(+) immunoselection;Engelhardt;Journal of clinical oncology: official journal of the American Society of Clinical Oncology,1999

5. Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis;Cutler;Journal of clinical oncology: official journal of the American Society of Clinical Oncology,2001

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sysmex XN-HPC: study of reference intervals and clinical decision limits in healthy allogeneic donors mobilised with G-CSF;Clinical and Experimental Medicine;2024-08-24

2. Predictive model of the efficiency of hematopoietic stem cell collection in patients with multiple myeloma and lymphoma based on multiple peripheral blood markers;International Journal of Laboratory Hematology;2024-07-03

3. Single Apheresis Session on the 4th Day of Granulocyte Colony-Stimulating Factor Administration Seems Convenient to Collect Enough Peripheral Blood Stem Cells from Healthy Donors;Transfusion Medicine and Hemotherapy;2024-06-04

4. Day 4 collection of granulocyte colony-stimulating factor-mobilized HLA-matched sibling donor peripheral blood allografts demonstrates no long-term increase in chronic graft-versus-host disease or relapse rates;Cytotherapy;2023-04

5. Optimal timing of apheresis for the efficient mobilization of peripheral blood progenitor cells recruited by high-dose granulocyte colony-stimulating factor in healthy donors;Transfusion and Apheresis Science;2020-06